Start-up TransEnterix secures head of Cordis as CEO
This article was originally published in Clinica
TransEnterix (Research Triangle Park, North Carolina), an early-stage developer of a minimally-invasive abdominal surgery device, has appointed Todd Pope as its first CEO and president. Mr Pope has nearly 20 years’ experience in the medtech industry, across various sectors, including cardiovascular, peripheral vascular, neurovascular and laparoscopic surgery. He joins from Johnson & Johnson’s Cordis, where he was worldwide president. “Preparing to enter the extensive minimally-invasive market, which is expected to be worth $8bn globally in 2008, it is essential to have a seasoned and successful CEO leadership,” said Fred McCoy, chairman of the board. The $21m-backed TransEnterix was established by Synecor, which is said to be backed by a $142m VC fund.